Formation of barrier layer

a barrier layer and layer technology, applied in the field of barrier layers, can solve the problems of structural weakness, difficult handling of adhesion barrier products, and difficult application to the targeted location of adhesion prevention and adhesion barrier products,

Inactive Publication Date: 2006-03-30
ATRIUM MEDICAL
View PDF30 Cites 88 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0009] What is desired is a barrier layer having uniform consistent coverage. The present invention is directed toward solutions to address this need. In accordance with the present invention a method and device for applying a barrier to a medical device, such as a surgical mesh, are provided that can produce uniform consistent coverage in a repeatable and controllable manner.
[0019] In accordance with further aspects of the present invention, the device can maintain the biocompatible medical device in a substantially horizontal orientation as the barrier layer is applied.

Problems solved by technology

However, such commercially available adhesion prevention and adhesion barrier products often are difficult to handle and apply to the targeted location due to their chemical make up and bio-dissolvable properties.
The composition and structural properties of these bio-dissolvable products require that they be handled with dry hands or instruments, which can be difficult during most surgical intervention operations.
Furthermore, many of these bio-dissolvable films are made intentionally to be thin to minimize tissue disruption and consequently end up being structurally weak (i.e., easily torn or folded during handling).
If a mesh does not have proper coverage then there may be areas of the mesh that does not have proper barrier protection which can lead to all the problems typically associated with uncoated meshes.
Similar problems can arise when the coating is not uniform.
Non-uniform coatings can cause inconsistent interactions, especially when a therapeutic agent is being delivered.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Formation of barrier layer
  • Formation of barrier layer
  • Formation of barrier layer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0036] The present invention relates to the provision of a barrier layer that can exhibit anti-inflammatory properties, non-inflammatory properties, and anti-adhesion properties, and corresponding method of making. The barrier layer can be its own medical device (i.e., a stand alone film), or the barrier layer can be combined with another medical device to provide anti-adhesion characteristics, in addition to improved healing and delivery of therapeutic agents. The barrier layer is generally formed of a naturally occurring oil, or an oil composition formed in part of a naturally occurring oil. In addition, the oil composition can include a therapeutic agent component, such as a drug or other bioactive agent. The barrier layer is implantable in a patient for short term or long term applications, and can include controlled release of the therapeutic agent. As implemented herein, the barrier layer is a non-polymeric cross-linked gel derived at least in part from a fatty acid compound. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
biocompatibleaaaaaaaaaa
bio-absorbableaaaaaaaaaa
anti-adhesionaaaaaaaaaa
Login to view more

Abstract

A barrier layer and corresponding method of making provide anti-inflammatory and anti-adhesion functionality for a medical device implantable in a patient. The barrier layer can be combined with a medical device structure to provide anti-adhesion characteristics, in addition to improved healing and anti-inflammatory response. The barrier layer is generally formed of a naturally occurring oil, or an oil composition formed in part of a naturally occurring oil, that is at least partially cured forming a cross-linked gel derived from at least one fatty acid compound. In addition, the oil composition can include a therapeutic agent component, such as a drug or other bioactive agent.

Description

RELATED APPLICATIONS [0001] This application claims priority to, and the benefit of, co-pending U.S. Provisional Application No. 60 / 613808, filed Sep. 28, 2004, for all subject matter common to both applications. The disclosure of said provisional application is hereby incorporated by reference in its entirety. This application also relates to co-pending U.S. patent application Ser. No. ______ (Attorney Docket No. ATA-427), filed concurrently with this application on Sep. 28, 2005.FIELD OF THE INVENTION [0002] The present invention relates to barrier layers that are able to provide anti-adhesion, anti-inflammatory, and wound healing functionality, with the potential to deliver therapeutic agents to a targeted location, while adhering to a medical device, and more specifically the application of barrier layers to biocompatible mesh structures. BACKGROUND OF THE INVENTION [0003] Biocompatible medical film is often used in surgical settings. For example, Seprafilm®, a product of Genzym...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61F2/00B05D3/00
CPCA61F2/06A61L27/3604A61F13/023A61F2250/0067A61K9/0024A61K9/06A61K31/225A61K31/355A61K47/12A61K47/14A61L2/07A61L2/081A61L2/087A61L2/206A61L2/208A61L27/36A61L27/52A61L27/54A61L31/005A61L31/10A61L31/145A61L2202/24A61L2300/22A61L2300/252A61L2300/404A61L2300/41A61L2300/414A61L2300/42A61L2300/602B05D3/067A61K35/60A61K38/13A61F13/02
Inventor FERRARO, JOSEPHROGERS, LISAMARTAKOS, PAULKARWOSKI, THEODOREHERWECK, STEVE A.FAUCHER, KEITHMCNAMARA, PHILIPQUIGLEY, WILLIAMAVELLA, MARK D.CHENEL, RICK
Owner ATRIUM MEDICAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products